Facebook
Twitter
Telegram
Report an ErrorMatinas BioPharma Holdings Financial Statements 2011-2024 | MTNB
Annual Financial Statements Matinas BioPharma Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
80.4 M | 97.6 M | 212 M | 290 M | 200 M | 96.1 M | 104 M | 126 M | 30.9 M | 16 M | - | - | - |
Shares |
217 M | 217 M | 210 M | 199 M | 145 M | 98.1 M | 90.5 M | 57.7 M | 51.5 M | 32.1 M | - | - | - |
Historical Prices |
0.37 | 0.45 | 1.01 | 1.36 | 2.27 | 0.595 | 1.16 | 1.4 | 0.85 | 0.45 | - | - | - |
Net Income |
-22.9 M | -21 M | -23.3 M | -22.4 M | -17.4 M | -14.1 M | -15.5 M | -7.6 M | -9.14 M | -10.2 M | -3.71 M | - | - |
Revenue |
1.1 M | 3.19 M | 33 K | 158 K | 89.8 K | 120 K | 150 K | - | 194 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 158 | - | - | - | - | 194 K | - | - | - | - |
Operating Income |
-23.8 M | -24.6 M | -24.7 M | -24.2 M | -18.9 M | -14.6 M | -16.5 M | -8.26 M | -9.91 M | -10.5 M | -3.71 M | - | - |
Interest Expense |
340 K | 102 K | 124 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-23.4 M | -24.3 M | -24.5 M | -23.4 M | -18.1 M | -14.4 M | -16.4 M | -8.2 M | -9.87 M | -10.4 M | -3.71 M | - | - |
Operating Expenses |
- | - | - | 24.4 M | 19 M | 14.8 M | 16.7 M | 8.26 M | 10.1 M | 10.5 M | - | - | - |
General and Administrative Expenses |
10.4 M | 11.1 M | 100 K | 10 M | 7.78 M | 7.98 M | 7.64 M | 4.31 M | 4.81 M | 5.29 M | 1.95 M | - | - |
All numbers in USD currency
Quarterly Income Statement Matinas BioPharma Holdings
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
217 M | 217 M | 217 M | 217 M | 217 M | 217 M | 217 M | 216 M | 215 M | 205 M | 204 M | 200 M | 199 M | 198 M | 192 M | 163 M | 157 M | 143 M | 117 M | 113 M | 94.7 M | 94 M | 93.5 M | 93.4 M | 92.2 M | 91.6 M | 84.6 M | 58.2 M | 57.6 M | 57.6 M | 57.3 M | 57.2 M | 57 M | 55.9 M | 35.6 M | 32.3 M | 32.1 M | 32 M | 32 M | 32 M | 14.9 M | 10 M | 10 M | - | - | - | - | - | - | - | - |
Net Income |
-6.06 M | -6.06 M | -5.51 M | - | -5.46 M | -5.92 M | -5.98 M | - | -6.84 M | -4.79 M | -4.96 M | - | -5.45 M | -5.61 M | -5.05 M | - | -4.4 M | -3.34 M | -4.05 M | - | -2.94 M | -3.41 M | -4.11 M | - | -3.39 M | -3.97 M | -4.5 M | - | -1.84 M | -1.62 M | -2.24 M | - | 7.1 M | 9.1 M | -9.1 M | - | 10.2 M | 10.2 M | -10.2 M | - | -1.46 M | -343 K | -112 K | - | - | - | - | - | - | - | - |
Revenue |
- | - | 1.1 M | - | 1.06 M | 1.06 M | - | - | 33.3 K | 33.3 K | 33.3 K | - | 95.8 K | - | - | - | 89.8 K | 89.8 K | - | - | 120 K | 89.8 K | 29.9 K | - | 44.9 K | 44.9 K | 15 K | - | - | - | - | - | 59.9 K | 77 K | 57.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.13 M | -6.16 M | -5.59 M | - | -5.46 M | -5.92 M | -7.72 M | - | -6.88 M | -4.79 M | -6.35 M | - | -5.6 M | -5.77 M | -6.35 M | - | -4.56 M | -4.52 M | -4.1 M | - | -2.95 M | -3.4 M | -4.12 M | - | -3.41 M | -3.98 M | -4.49 M | - | -1.84 M | -1.62 M | -2.24 M | - | -2.16 M | -2.4 M | -2.57 M | - | -2.61 M | -2.42 M | -2.13 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
79 K | 99 K | 73 K | - | 988 | 2 K | 10 K | - | 41.4 K | -1.42 K | - | - | - | 156 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-6.04 M | -6.06 M | -5.49 M | - | -5.37 M | -5.84 M | -7.65 M | - | -6.7 M | -4.67 M | -6.29 M | - | -5.43 M | -5.65 M | -6.29 M | - | -4.41 M | -4.42 M | -4.06 M | - | -2.8 M | -3.3 M | -4.07 M | - | -3.35 M | -3.96 M | -4.48 M | - | -1.8 M | -1.61 M | -2.22 M | - | -2.13 M | -2.38 M | -2.56 M | - | -2.55 M | -2.4 M | -2.12 M | - | 662 | 3.58 K | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.45 M | 4.02 M | 4.5 M | - | 1.84 M | 1.62 M | 2.24 M | - | 2.22 M | 2.48 M | 2.63 M | - | 2.61 M | 2.42 M | 2.13 M | - | 1.45 M | 343 K | 112 K | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.84 M | 2.6 M | 2.71 M | - | 2.82 M | 2.86 M | 2.74 M | - | 29 K | 28 K | 20 K | - | 90 K | 93 K | 80 K | - | 62.1 K | 58.7 K | 117 K | - | 485 K | 342 K | 172 | - | 1.44 M | 1.71 M | 2.12 M | - | 1 M | 978 K | 1.32 M | - | 1.34 M | 1.12 M | 1.18 M | - | 1.54 M | 1.3 M | 1.06 M | - | 708 K | 103 K | 62.5 K | - | - | - | - | - | - | - | - |
All numbers in USD currency